Eric Garnier

Eric Garnier currently holds the position of Président Comité Stratégique at Aenitis Technologies since July 2024 and serves as a strategic committee member for multiple organizations, including SEPARATIVE, GAOMA Therapeutics, BrainTale, and myNUMEA. In addition to these roles, Eric Garnier is an Expert & Selection Committee Member at WILCO and has been President of both Asgardia Conseil and Angels Santé since April 2019. Previously, Eric Garnier was a Senior Advisor & Member of the Strategic Committee at SEPARATIVE until November 2023 and contributed to SentinHealth as a member of its Strategic Committee from June 2022 to July 2023. Educational qualifications include an MBA in Finance and Marketing from ISG Institut Supérieur de Gestion and a board membership certification from emlyon business school.